Policy Brief Issue 149: Health Financing during COVID-19 responses in Thailand
- Thailand spent 440,023 million baht on healthcare in response to the COVID-19 pandemic in 2020–2022, of which 257,892 million baht went toward COVID ...Read more
- Thailand spent 440,023 million baht on healthcare in response to the COVID-19 pandemic in 2020–2022, of which 257,892 million baht went toward COVID ...Read more
Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PMJAY) is the largest public health insurance scheme in the world that is fully funded by the gov ...Read more
The Cancer Drug Fund (CDF) is a dedicated source of funding in England for increasing patient access to high-cost cancer drugs, with a fixed budget of ...Read more
Cancer Drug Fund (CDF) เป็นกองทุนในอังกฤษเพื่อเพิ่มการเข้าถึงยารักษามะเร็งที่มีราคาสูง กองทุนนี้เริ่มดำเนินการมาตั้งแต่ พ.ศ. 2559 และมีงบประมาณ 340 ล้ ...Read more
The introduction of Coronavirus disease 2019 (COVID-19) vaccines urged all Thais to seek prevention of serious illness and death from COVID-19. Howeve ...Read more
Digital health interventions (DHIs), such as electronic decision support tools, telemonitoring, or mobile health (mHealth) apps, have the potential to ...Read more
Horizon Scanning (HS) is the process of identifying new and emerging technologies before uptake into practice to evaluate the potential impact to info ...Read more
With countries progressing towards high COVID-19 vaccination rates, strategies for border reopening are required. This study focuses on Thailand and S ...Read more
This report summarizes the discussion during two meetings held on 28th and 29th November 2022 to discuss the technical components of the COVID-19 epid ...Read more
Australia developed the Life-Saving Drugs Program (LSDP) in 1995 to complement the Pharmaceutical Benefits Scheme (PBS), expanding access to high-cost ...Read more